The efficacy and safety of the Cefaly (R) medical device for migraine treatment had already been reported early 2013 in the scientific journal "Neurology" (Official Journal of the American Academy of Neurology). Published data on a large number of individuals confirm the significant improvement for a majority of patients. Following 2 months of treatment, 54.4% of the patients described a very substantial improvement and decided to purchase the device.
No comments:
Post a Comment